The dopamine agonist piribédil with L-Dopa improves attentional dysfunction : relevance for Parkinson's disease - Vigipallia

0 avis

The dopamine agonist piribédil with L-Dopa improves attentional dysfunction : relevance for Parkinson's disease

Archive ouverte

Turle-Lorenzo, N. | Maurin, B. | Puma, C. | Chezaubernard, C. | Morain, P. | Baunez, C. | Nieoullon, A. | Amalric, Marianne

Edité par CCSD ; American Society for Pharmacology and Experimental Therapeutics -

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Functional interaction between .mGlu5 and NMDA receptors in a rat model of Parkinson's disease.

Archive ouverte | Turle-Lorenzo, N. | CCSD

Intrapallidal injections of group III metabotropic glutamate receptors agonist reduce akinetic deficits in parkinsonian rats.

Archive ouverte | Lopez, S. | CCSD

Differential roles of group III metabotropic glutamate receptors in the basal ganglia in regulating motor control of parkinsonian rats.

Archive ouverte | Amalric, Marianne | CCSD

Chargement des enrichissements...